220 related articles for article (PubMed ID: 28602870)
1. Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection.
Huang D; Chen YS; Thakur SS; Rupenthal ID
Eur J Pharm Biopharm; 2017 Oct; 119():125-136. PubMed ID: 28602870
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-responsive nanobubbles for enhanced intravitreal drug migration: An ex vivo evaluation.
Thakur SS; Chen YS; Houston ZH; Fletcher N; Barnett NL; Thurecht KJ; Rupenthal ID; Parekh HS
Eur J Pharm Biopharm; 2019 Mar; 136():102-107. PubMed ID: 30660691
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Monitoring of Choroid-Retina Autofluorescence and Intravitreal Nanoparticle Disposition in Royal College of Surgeon Rats of Different Ages and Retinal Thinning.
Patil MA; Kompella UB
J Ocul Pharmacol Ther; 2020; 36(6):458-466. PubMed ID: 32552217
[No Abstract] [Full Text] [Related]
4. Intravitreal nanoparticles for retinal delivery.
Huang X; Chau Y
Drug Discov Today; 2019 Aug; 24(8):1510-1523. PubMed ID: 31102730
[TBL] [Abstract][Full Text] [Related]
5. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection.
Koo H; Moon H; Han H; Na JH; Huh MS; Park JH; Woo SJ; Park KH; Kwon IC; Kim K; Kim H
Biomaterials; 2012 Apr; 33(12):3485-93. PubMed ID: 22322197
[TBL] [Abstract][Full Text] [Related]
6. Role of retinal pigment epithelium permeability in drug transfer between posterior eye segment and systemic blood circulation.
Ramsay E; Hagström M; Vellonen KS; Boman S; Toropainen E; Del Amo EM; Kidron H; Urtti A; Ruponen M
Eur J Pharm Biopharm; 2019 Oct; 143():18-23. PubMed ID: 31419586
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic Acid Coated Albumin Nanoparticles for Targeted Peptide Delivery to the Retina.
Huang D; Chen YS; Rupenthal ID
Mol Pharm; 2017 Feb; 14(2):533-545. PubMed ID: 27997199
[TBL] [Abstract][Full Text] [Related]
8. Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes.
Kadam RS; Williams J; Tyagi P; Edelhauser HF; Kompella UB
Mol Vis; 2013; 19():1198-210. PubMed ID: 23734089
[TBL] [Abstract][Full Text] [Related]
9. Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy.
Martens TF; Peynshaert K; Nascimento TL; Fattal E; Karlstetter M; Langmann T; Picaud S; Demeester J; De Smedt SC; Remaut K; Braeckmans K
Eur J Pharm Sci; 2017 May; 103():27-35. PubMed ID: 28223236
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid coating of gold nanoparticles for intraocular drug delivery: Evaluation of the surface properties and effect on their distribution.
Apaolaza PS; Busch M; Asin-Prieto E; Peynshaert K; Rathod R; Remaut K; Dünker N; Göpferich A
Exp Eye Res; 2020 Sep; 198():108151. PubMed ID: 32721426
[TBL] [Abstract][Full Text] [Related]
11. Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina.
Kim H; Robinson SB; Csaky KG
Pharm Res; 2009 Feb; 26(2):329-37. PubMed ID: 18958405
[TBL] [Abstract][Full Text] [Related]
12. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
Li J; Lan B; Li X; Sun S; Lu P; Cheng L
J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan-modified core-shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection.
Gan L; Wang J; Zhao Y; Chen D; Zhu C; Liu J; Gan Y
Biomaterials; 2013 Aug; 34(24):5978-87. PubMed ID: 23680367
[TBL] [Abstract][Full Text] [Related]
14. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration.
Amrite AC; Edelhauser HF; Singh SR; Kompella UB
Mol Vis; 2008 Jan; 14():150-60. PubMed ID: 18334929
[TBL] [Abstract][Full Text] [Related]
15. Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroids.
Thakur A; Kadam RS; Kompella UB
Drug Metab Dispos; 2011 May; 39(5):771-81. PubMed ID: 21346004
[TBL] [Abstract][Full Text] [Related]
16. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy.
Martens TF; Remaut K; Deschout H; Engbersen JF; Hennink WE; van Steenbergen MJ; Demeester J; De Smedt SC; Braeckmans K
J Control Release; 2015 Mar; 202():83-92. PubMed ID: 25634806
[TBL] [Abstract][Full Text] [Related]
17. Effects of enzymatic degradation on dynamic mechanical properties of the vitreous and intravitreal nanoparticle mobility.
Huang D; Chen YS; Xu Q; Hanes J; Rupenthal ID
Eur J Pharm Sci; 2018 Jun; 118():124-133. PubMed ID: 29574081
[TBL] [Abstract][Full Text] [Related]
18. Ocular barriers to retinal delivery of intravitreal liposomes: Impact of vitreoretinal interface.
Tavakoli S; Peynshaert K; Lajunen T; Devoldere J; Del Amo EM; Ruponen M; De Smedt SC; Remaut K; Urtti A
J Control Release; 2020 Dec; 328():952-961. PubMed ID: 33091527
[TBL] [Abstract][Full Text] [Related]
19. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
20. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.
Bourges JL; Gautier SE; Delie F; Bejjani RA; Jeanny JC; Gurny R; BenEzra D; Behar-Cohen FF
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3562-9. PubMed ID: 12882808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
